Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
DIACC-3010 by Evexta Bio for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
DIACC-3010 is under clinical development by Evexta Bio and currently in Phase I for Human Epidermal Growth Factor Receptor 2...
DIACC-3010 by Evexta Bio for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
DIACC-3010 is under clinical development by Evexta Bio and currently in Phase I for Human Epidermal Growth Factor Receptor 2...
DIACC-3010 by Evexta Bio for Lymphoma: Likelihood of Approval
DIACC-3010 is under clinical development by Evexta Bio and currently in Phase I for Lymphoma. According to GlobalData, Phase I...
DIACC-3010 by Evexta Bio for Gastric Cancer: Likelihood of Approval
DIACC-3010 is under clinical development by Evexta Bio and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...